ArticleScientific reports2025
Fuzzy and fractional analysis of cancer tumor dynamics with depression effects on chemotherapy.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Fixed-point topology meets fractal memory: a Kutumba-stabilized framework for nonlocal fractal-fractional dynamics.Scientific reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cancer is a complex and heterogeneous condition marked by the unchecked growth and dissemination of abnormal cells, posing significant challenges in detection, treatment, and patient care. As one of the leading global causes of death, a deep understanding of its underlying biological mechanisms is essential for advancing therapeutic strategies and improving clinical outcomes. Mathematical modeling serves as a crucial tool in capturing the multifaceted dynamics of cancer initiation, progression, and response to interventions. By simulating critical aspects of cancer within a controlled computational framework, mathematical models enable scientists to explore innovative treatment strategies, investigate the disease's underlying biological dynamics, and identify novel therapeutic targets. This study presents a fuzzy-fractional differential model of tumor-immune interaction, incorporating tumor cells, immune effector cells, and the concentration of chemotherapy agents in the bloodstream, modeled using Caputo-type time-fractional derivatives. To better capture the uncertainty associated with patient-specific factors-particularly psychological impacts such as depression-triangular fuzzy numbers are integrated into the initial conditions, thereby enhancing the model's realism and predictive capability. The current model is addressed using the proposed modified He-Laplace-Carson algorithm for solution and analysis by creating multiple homotopies related to the perturbation method. The model's solution trajectories for chemotherapy levels, immune effector cells, and tumor cell populations are examined to evaluate the bidirectional interaction between immune response and tumor growth. Additionally, the simulation provides insight into the dynamic behavior of chemotherapy concentration over the duration of treatment, offering a clearer understanding of its therapeutic progression. An extensive graphical analysis is conducted by varying a range of parameters, including effect of depression, death rate of immune cells due to malignant cells attachment, maximum growth rate factors, and fuzzy parameters introduced in the cancer system. It was observed that as the fractional parameter ξ increased, all profiles rose, with effector cells showing a more notably faster growth than tumor cells. Furthermore, all fuzzy and non-fuzzy parameters generally showed a strong positive influence on effector cells, with tumor cell growth remaining comparatively subdued. The fractional parameter is analyzed under diverse conditions using 2D/3D visualizations and contour gradients, confirming the method's reliability in handling uncertainty and highlighting its adaptability to broader fuzzy-fractional systems. Such applications have the capability to significantly enhance the understanding of ongoing challenges faced in oncology.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.